anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Nuvectis Pharma · pitchdeck

Nuvectis Pharma | Investor Presentation Deck | 23 slides

23 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Nuvectis Pharma | Investor Presentation Deck | 23 slides

Nuvectis Pharma · 2023-07
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 10 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 3 slides 100% 3/3 slides 100% 3/3 slides · 16 hits
— 0/3 slides
33.3% 1/3 slides 33.3% 1/3 slides 100% 3/3 slides · 4 hits
— 0/3 slides
Solution 5 slides 100% 5/5 slides 100% 5/5 slides · 32 hits
— 0/5 slides
20% 1/5 slides 20% 1/5 slides 100% 5/5 slides 60% 3/5 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides · 2 hits
— 0/1 slides

Slide inventory

23
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
summarize
Open slide detailBeat · Problem
04
The slide uses a visual association between the three executives and the logos of companies/products they have been associated with.other
Open slide detailBeat · Problem
05
The slide uses a timeline-style layout to represent drug development stages.plan_implementation
Open slide detailBeat · Problem
06
transition
Open slide detail
07
summarize
Open slide detailBeat · Solution
08
Includes a detailed biological pathway diagram and a Western blot image as evidence.present_solution
Open slide detailBeat · Solution
09
The slide demonstrates superior tumor volume reduction by NXP800 compared to standard-of-care Cisplatin in both SKOV-3 and TOV-21G models.show_traction
Open slide detailBeat · SolutionLoop · Cost Of Inaction
10
Includes a patient-derived xenograft (PDX) study workflow diagram and a tumor volume growth curve.show_traction
Open slide detailBeat · SolutionLoop · Cost Of Inaction
11
The chart shows tumor volume reduction over 28 days compared to vehicle control.show_traction
Open slide detailBeat · SolutionLoop · Cost Of Inaction
12
The slide uses a split-column layout to contrast the completed Phase 1a with the active Phase 1b.plan_implementation
Open slide detailBeat · Market Size
13
transition
Open slide detail
14
summarize
Open slide detail
15
The visualization is a standard kinome tree map used in pharmaceutical research to demonstrate drug selectivity.compare_peers
Open slide detail
16
The slide uses a structural biology diagram to illustrate the mechanism of action (MOA) differentiation.present_solution
Open slide detail
17
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.present_solution
Open slide detail
18
The charts demonstrate efficacy in specific cell lines (KYSE70 and Cal27) with known genetic alterations.show_traction
Open slide detailLoop · Quick Win Big Bet
19
The slide presents preclinical data supporting the efficacy of NXP900 in combination therapies.present_solution
Open slide detailLoop · Quick Win Big Bet
20
Clinical trial identifier NCT05873686 is provided.plan_implementation
Open slide detailLoop · Quick Win Big Bet
21
summarize
Open slide detail
22
The slide uses a chevron-style list layout to categorize highlights.summarize
Open slide detail
23
front_matter
Open slide detail